Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel

Journal of Infectious Diseases

Volumn 206, Issue 7, 2012, Pages 993-1001

  Naranbhai, Vivek ^a,b   Abdool Karim, Salim S ^a,c   Altfeld, Marcus ^b,d   Samsunder, Natasha ^a   Durgiah, Raveshni ^b   Sibeko, Sengeziwe ^a   Abdool Karim, Quarraisha ^a,c   Carr, William H ^b,d  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c Massachusetts Institute of Technology and Harvard ^*  (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MICROBICIDE; PLACEBO; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GEL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION PREVENTION; INNATE IMMUNE ACTIVATION; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE; VIRUS TRANSMISSION;

ADENINE; ADULT; ANTI-HIV AGENTS; AVIAN PROTEINS; CASE-CONTROL STUDIES; COINFECTION; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; LOGISTIC MODELS; LYMPHOCYTE ACTIVATION; ORGANOPHOSPHONATES; PLATELET COUNT; PRINCIPAL COMPONENT ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT;

EID: 84866137168     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis465     Document Type: Conference Paper

References (50)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. 2010.
2. Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol 2011; 40(4):922-30.
3. Abdool Karim Q, Sibeko S, Baxter C. Preventing HIV infection in women: a global health imperative. Clin Infect Dis 2010; 50(Suppl 3): S122-9.
4. Abdool Karim SS, Abdool Karim Q. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet 2011; 378(9809):e23-5.
5. FHI. Press Release: FHI to Initiate Orderly Closure of FEM-PrEP. 2011.
6. MTN. Press Release: MTN statement on decision to discontinue use of oral tenofovir tablets in VOICE, a Major HIV Prevention Study in Women. 2011.
7. Centers for Disease Control and Prevention (CDC). Press Release: CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals. 2011.
8. University of Washington International Clinical Research Center. Press Release: Partners PrEP Study. Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa. 2011.
9. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-74.
10. Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. Trials 2011; 12:67.
11. Begaud E, Chartier L, Marechal V, et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfect-ed Central Africans. Retrovirology 2006; 3:35.
12. + T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 2010; 202(Suppl 3):S339-44.
13. Pancino G, Saez-Cirion A, Scott-Algara D, Paul P. Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 2010; 202(Suppl 3):S345-50.
14. Jennes W, Evertse D, Borget MY, et al. Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. Clin Exp Immunol 2006; 143:435-44.
15. Biasin M, Caputo SL, Speciale L, et al. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J Infect Dis 2000; 182:1365-74.
16. Jennes W, Sawadogo S, Koblavi-Deme S, et al. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIVexposed seronegative female sex workers and female blood donors in Abidjan, Cote d'Ivoire. J Infect Dis 2003; 187:206-14. (Pubitemid 36132634)
17. Suy A, Castro P, Nomdedeu M, et al. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation. J Infect Dis 2007; 196:1191-201. (Pubitemid 47580274)
18. Tomescu C, Duh FM, Lanier MA, et al. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS 2011; 24:2151-60.
19. Tran HK, Chartier L, Troung LX, et al. Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses 2006; 22:255-61.
20. Naranbhai V, Bartman P, Ndlovu D, et al. Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function. J Immunol Methods 2011; 366:28-35.
21. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22. (Pubitemid 39626587)
22. Soares A, Govender L, Hughes J, et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 2010; 362:43-50.
23. Harrison D, Phillips JH, Lanier LL. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 1991; 147:3459-65.
24. Milush JM, Long BR, Snyder-Cappione JE, et al. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood 2009; 114:4823-31.
25. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-36. (Pubitemid 350179568)
26. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-34. (Pubitemid 35154456)
27. Long BR, Erickson AE, Chapman JM, et al. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology 2010; 129:186-96.
28. Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, Clerici M. The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS 2009; 23:161-75.
29. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-29.
30. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood 2009; 114:2367-74.
31. Ramsuran V, Kulkarni H, He W, et al. Duffy-Null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clin Infect Dis 2011; 52:1248-56.
32. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006; 118:1-10. (Pubitemid 43012040)
33. Lopez-Verges S, Milush JM, Pandey S, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010; 116:3865-74.
34. Malavasi F, Deaglio S, Funaro A, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88:841-86.
35. Mallone R, Funaro A, Zubiaur M, et al. Signaling through CD38 induces NK cell activation. Int Immunol 2001; 13:397-409. (Pubitemid 32288538)
36. Sconocchia G, Titus JA, Mazzoni A, et al. CD38 triggers cytotoxic responses in activated human natural killer cells. Blood 1999; 94:3864-71.
37. Deaglio S, Zubiaur M, Gregorini A, et al. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 2002; 99:2490-8. (Pubitemid 34586752)
38. Funaro A, Reinis M, Trubiani O, Santi S, Di Primio R, Malavasi F. CD38 functions are regulated through an internalization step. J Immunol 1998; 160:2238-47. (Pubitemid 28119904)
39. Savarino A, Bottarel F, Malavasi F, Dianzani U. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 2000; 14:1079-89. (Pubitemid 30420650)
40. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008; 22:595-9. (Pubitemid 351640592)
41. Jennes W, Verheyden S, Demanet C, et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006; 177:6588-92. (Pubitemid 44715020)
42. Ravet S, Scott-Algara D, Bonnet E, et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIVexposed uninfected individuals. Blood 2007; 109:4296-305. (Pubitemid 46743396)
43. Norman PJ, Abi-Rached L, Gendzekhadze K, et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 2007; 39:1092-9. (Pubitemid 47340657)
44. Shapira-Nahor O, Kalinkovich A, Weisman Z, et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 1998; 12: 1731-3. (Pubitemid 28418353)
45. Jaspan HB, Liebenberg L, Hanekom W, et al. Immune activation in the female genital tract during HIV Infection predicts mucosal CD4 depletion and HIV shedding. J Infect Dis 2011; 204:1550-6.
46. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-23.
47. Roberts L, Passmore J, Williamson C, et al. Genital tract inflammation in women participating in the CAPRISA TFV Microbicide Trial who became infected with HIV: A mechanism for breakthrough infection? In: 18th Conference on Retroviruses and Opportunistic Infections. (Boston, MA, USA).
48. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V. HIV-asso-ciated immune activation: from bench to bedside. AIDS Res Hum Ret-roviruses 2011; 27:355-64.
49. + T-cell recovery on antiretroviral therapy. J Infect Dis 2011; 203:1474-83.
50. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-8.